Global Keloid Treatment Market- Industry Analysis and forecast 2019 – 2027: By Treatment Type, End-User, and Region.

Global Keloid Treatment Market- Industry Analysis and forecast 2019 – 2027: By Treatment Type, End-User, and Region.

Market Scenario

Global Keloid Treatment Market size was valued US$ XX Bn. in 2019 and the total revenue is expected to grow at 5.3% from 2019 to 2027, reaching nearly US$ XX Bn.   Global Keloid Treatment Market The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis. Keloid treatment contains corticosteroid injections or intraregional steroids in which they are good but quite pain-causing. Laser treatment of keloid includes the pulsed type dye laser that can be good at flattening the keloids & appearing them little less red. The MMR report contains a detailed study of factors that will drive and restrain the growth of the keloid treatment market. Such as, the upsurge in expenditure on personal care products significantly contributes towards the development of the keloid treatment market globally. Keloids can appear anywhere on the body and affect an expected 10-15% of all wounds. According to the National Institute of Health, Keloid scars are most common in people with the age group of 10 years to 30 years. Keloid scars are usually seen in Asians, African Americans, or Hispanic descents. Expanding awareness regarding appearance and looks among people is the major fueling factor for the global keloid treatment market. The availability of technologically advanced products like laser instruments, at lower costs is expected to boost their adoption, coupled with a significant presence of target population in the APAC is driving market expansion. Such as, there are more than 10 million cases each year in India only. As per the WHO (World Health Organization), in India, above 1,000,000 people are moderately burnt yearly. Companies in the global keloid treatment market are more focused on enhancing their product and service offerings through many strategic approaches. Such as, in 2019, Xstrahl Medical, one of the major companies in superficial radiotherapy devices to treat dermatological conditions and, launched its newest superficial radiotherapy treatment system. The MMR report will provide an accurate prediction of the contribution of the various segments to the growth of the keloid treatment market size. By end-user, the hospitals segment was valued at US$ XX.24 Mn in 2019 and is expected to reach US$ XX.43 Mn by 2027 at a CAGR of XX.34% during the forecast period. This is because of high patient footfalls in the hospitals for any treatment as hospitals are highly preferred over other treatment centers. North America is expected to continue to hold the largest XX.76% share in keloid treatment market because of the high prevalence skin-related disorders and trauma coupled with the relatively high and easy availability as well as the adoption of new technologies, products, and treatment alternatives. For example, there are about 93 million people in the U.S. suffering from scars, out of which about 169 million scars can be characterized as hypertrophic and keloid scars. Yearly, 1.1 million burn injuries need medical attention in the U.S. The objective of the report is to present a comprehensive analysis of the Global Keloid Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Keloid Treatment Market dynamics, structure by analyzing the market segments and projects the Global Keloid Treatment Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Keloid Treatment Market make the report investor’s guide.

Scope of the Global Keloid Treatment Market

Global Keloid Treatment Market, by Treatment Type

• Occlusive dressing • Compression therapy • Cryosurgery • Excision • Radiation therapy • Laser therapy • Interferon therapy • Intralesional corticosteroid injection • Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)

Global Keloid Treatment Market, by End User

• Hospitals • Dermatology clinics • Ambulatory surgical centers • Others

Global Keloid Treatment Market, by Region

• Asia Pacific • North America • Europe • South America • Middle East & Africa

Key players operating in Global Keloid Treatment Market

• Revitol Corporation Inc. • Xstrahl Medical • GlaxoSmithKline plc. • Bristol-Myers Squibb Company • Sensus Healthcare, Inc • Novartis AG, Renovo Group plc. • Bausch Health • Scarless Laboratories Inc. • Galena Biopharma, Inc. • RXi Pharmaceuticals, Inc. • Avita Medical • Perrigo Company • Soliton, Inc

Table of Contents

Global Keloid Treatment Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Keloid Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Keloid Treatment Market Analysis and Forecast 6.1. Keloid Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Keloid Treatment Market Analysis and Forecast, By End User 7.1. Introduction and Definition 7.2. Key Findings 7.3. Keloid Treatment Market Value Share Analysis, By End User 7.4. Keloid Treatment Market Size (US$ Bn) Forecast, By End User 7.5. Keloid Treatment Market Analysis, By End User 7.6. Keloid Treatment Market Attractiveness Analysis, By End User 8. Global Keloid Treatment Market Analysis and Forecast, By Treatment Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Keloid Treatment Market Value Share Analysis, By Treatment Type 8.4. Keloid Treatment Market Size (US$ Bn) Forecast, By Treatment Type 8.5. Keloid Treatment Market Analysis, By Treatment Type 8.6. Keloid Treatment Market Attractiveness Analysis, By Treatment Type 9. Global Keloid Treatment Market Analysis, by Region 9.1. Keloid Treatment Market Value Share Analysis, by Region 9.2. Keloid Treatment Market Size (US$ Bn) Forecast, by Region 9.3. Keloid Treatment Market Attractiveness Analysis, by Region 10. North America Keloid Treatment Market Analysis 10.1. Key Findings 10.2. North America Keloid Treatment Market Overview 10.3. North America Keloid Treatment Market Value Share Analysis, By End User 10.4. North America Keloid Treatment Market Forecast, By End User 10.4.1. Hospitals 10.4.2. Dermatology clinics 10.4.3. Ambulatory surgical centers 10.4.4. Others 10.5. North America Keloid Treatment Market Value Share Analysis, By Treatment Type 10.6. North America Keloid Treatment Market Forecast, By Treatment Type 10.6.1. Occlusive dressing 10.6.2. Compression therapy 10.6.3. Cryosurgery 10.6.4. Excision 10.6.5. Radiation therapy 10.6.6. Laser therapy 10.6.7. Interferon therapy 10.6.8. Intralesional corticosteroid injection 10.6.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 10.7. North America Keloid Treatment Market Value Share Analysis, by Country 10.8. North America Keloid Treatment Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Keloid Treatment Market Analysis, by Country 10.10. U.S. Keloid Treatment Market Forecast, By End User 10.10.1. Hospitals 10.10.2. Dermatology clinics 10.10.3. Ambulatory surgical centers 10.10.4. Others 10.11. U.S. Keloid Treatment Market Forecast, By Treatment Type 10.11.1. Occlusive dressing 10.11.2. Compression therapy 10.11.3. Cryosurgery 10.11.4. Excision 10.11.5. Radiation therapy 10.11.6. Laser therapy 10.11.7. Interferon therapy 10.11.8. Intralesional corticosteroid injection 10.11.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 10.12. Canada Keloid Treatment Market Forecast, By End User 10.12.1. Hospitals 10.12.2. Dermatology clinics 10.12.3. Ambulatory surgical centers 10.12.4. Others 10.13. Canada Keloid Treatment Market Forecast, By Treatment Type 10.13.1. Occlusive dressing 10.13.2. Compression therapy 10.13.3. Cryosurgery 10.13.4. Excision 10.13.5. Radiation therapy 10.13.6. Laser therapy 10.13.7. Interferon therapy 10.13.8. Intralesional corticosteroid injection 10.13.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 10.14. North America Keloid Treatment Market Attractiveness Analysis 10.14.1. By End User 10.14.2. By Treatment Type 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Keloid Treatment Market Analysis 11.1. Key Findings 11.2. Europe Keloid Treatment Market Overview 11.3. Europe Keloid Treatment Market Value Share Analysis, By End User 11.4. Europe Keloid Treatment Market Forecast, By End User 11.4.1. Hospitals 11.4.2. Dermatology clinics 11.4.3. Ambulatory surgical centers 11.4.4. Others 11.5. Europe Keloid Treatment Market Value Share Analysis, By Treatment Type 11.6. Europe Keloid Treatment Market Forecast, By Treatment Type 11.6.1. Occlusive dressing 11.6.2. Compression therapy 11.6.3. Cryosurgery 11.6.4. Excision 11.6.5. Radiation therapy 11.6.6. Laser therapy 11.6.7. Interferon therapy 11.6.8. Intralesional corticosteroid injection 11.6.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 11.7. Europe Keloid Treatment Market Value Share Analysis, by Country 11.8. Europe Keloid Treatment Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Keloid Treatment Market Analysis, by Country 11.10. Germany Keloid Treatment Market Forecast, By End User 11.10.1. Hospitals 11.10.2. Dermatology clinics 11.10.3. Ambulatory surgical centers 11.10.4. Others 11.11. Germany Keloid Treatment Market Forecast, By Treatment Type 11.11.1. Occlusive dressing 11.11.2. Compression therapy 11.11.3. Cryosurgery 11.11.4. Excision 11.11.5. Radiation therapy 11.11.6. Laser therapy 11.11.7. Interferon therapy 11.11.8. Intralesional corticosteroid injection 11.11.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 11.12. U.K. Keloid Treatment Market Forecast, By End User 11.12.1. Hospitals 11.12.2. Dermatology clinics 11.12.3. Ambulatory surgical centers 11.12.4. Others 11.13. U.K. Keloid Treatment Market Forecast, By Treatment Type 11.13.1. Occlusive dressing 11.13.2. Compression therapy 11.13.3. Cryosurgery 11.13.4. Excision 11.13.5. Radiation therapy 11.13.6. Laser therapy 11.13.7. Interferon therapy 11.13.8. Intralesional corticosteroid injection 11.13.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 11.14. France Keloid Treatment Market Forecast, By End User 11.14.1. Hospitals 11.14.2. Dermatology clinics 11.14.3. Ambulatory surgical centers 11.14.4. Others 11.15. France Keloid Treatment Market Forecast, By Treatment Type 11.15.1. Occlusive dressing 11.15.2. Compression therapy 11.15.3. Cryosurgery 11.15.4. Excision 11.15.5. Radiation therapy 11.15.6. Laser therapy 11.15.7. Interferon therapy 11.15.8. Intralesional corticosteroid injection 11.15.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 11.16. Italy Keloid Treatment Market Forecast, By End User 11.16.1. Hospitals 11.16.2. Dermatology clinics 11.16.3. Ambulatory surgical centers 11.16.4. Others 11.17. Italy Keloid Treatment Market Forecast, By Treatment Type 11.17.1. Occlusive dressing 11.17.2. Compression therapy 11.17.3. Cryosurgery 11.17.4. Excision 11.17.5. Radiation therapy 11.17.6. Laser therapy 11.17.7. Interferon therapy 11.17.8. Intralesional corticosteroid injection 11.17.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 11.18. Spain Keloid Treatment Market Forecast, By End User 11.18.1. Hospitals 11.18.2. Dermatology clinics 11.18.3. Ambulatory surgical centers 11.18.4. Others 11.19. Spain Keloid Treatment Market Forecast, By Treatment Type 11.19.1. Occlusive dressing 11.19.2. Compression therapy 11.19.3. Cryosurgery 11.19.4. Excision 11.19.5. Radiation therapy 11.19.6. Laser therapy 11.19.7. Interferon therapy 11.19.8. Intralesional corticosteroid injection 11.19.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 11.20. Rest of Europe Keloid Treatment Market Forecast, By End User 11.20.1. Hospitals 11.20.2. Dermatology clinics 11.20.3. Ambulatory surgical centers 11.20.4. Others 11.21. Rest of Europe Keloid Treatment Market Forecast, By Treatment Type 11.21.1. Occlusive dressing 11.21.2. Compression therapy 11.21.3. Cryosurgery 11.21.4. Excision 11.21.5. Radiation therapy 11.21.6. Laser therapy 11.21.7. Interferon therapy 11.21.8. Intralesional corticosteroid injection 11.21.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 11.22. Europe Keloid Treatment Market Attractiveness Analysis 11.22.1. By End User 11.22.2. By Treatment Type 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Developments 12. Asia Pacific Keloid Treatment Market Analysis 12.1. Key Findings 12.2. Asia Pacific Keloid Treatment Market Overview 12.3. Asia Pacific Keloid Treatment Market Value Share Analysis, By End User 12.4. Asia Pacific Keloid Treatment Market Forecast, By End User 12.4.1. Hospitals 12.4.2. Dermatology clinics 12.4.3. Ambulatory surgical centers 12.4.4. Others 12.5. Asia Pacific Keloid Treatment Market Value Share Analysis, By Treatment Type 12.6. Asia Pacific Keloid Treatment Market Forecast, By Treatment Type 12.6.1. Occlusive dressing 12.6.2. Compression therapy 12.6.3. Cryosurgery 12.6.4. Excision 12.6.5. Radiation therapy 12.6.6. Laser therapy 12.6.7. Interferon therapy 12.6.8. Intralesional corticosteroid injection 12.6.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 12.7. Asia Pacific Keloid Treatment Market Value Share Analysis, by Country 12.8. Asia Pacific Keloid Treatment Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Keloid Treatment Market Analysis, by Country 12.10. China Keloid Treatment Market Forecast, By End User 12.10.1. Hospitals 12.10.2. Dermatology clinics 12.10.3. Ambulatory surgical centers 12.10.4. Others 12.11. China Keloid Treatment Market Forecast, By Treatment Type 12.11.1. Occlusive dressing 12.11.2. Compression therapy 12.11.3. Cryosurgery 12.11.4. Excision 12.11.5. Radiation therapy 12.11.6. Laser therapy 12.11.7. Interferon therapy 12.11.8. Intralesional corticosteroid injection 12.11.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 12.12. India Keloid Treatment Market Forecast, By End User 12.12.1. Hospitals 12.12.2. Dermatology clinics 12.12.3. Ambulatory surgical centers 12.12.4. Others 12.13. India Keloid Treatment Market Forecast, By Treatment Type 12.13.1. Occlusive dressing 12.13.2. Compression therapy 12.13.3. Cryosurgery 12.13.4. Excision 12.13.5. Radiation therapy 12.13.6. Laser therapy 12.13.7. Interferon therapy 12.13.8. Intralesional corticosteroid injection 12.13.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 12.14. Japan Keloid Treatment Market Forecast, By End User 12.14.1. Hospitals 12.14.2. Dermatology clinics 12.14.3. Ambulatory surgical centers 12.14.4. Others 12.15. Japan Keloid Treatment Market Forecast, By Treatment Type 12.15.1. Occlusive dressing 12.15.2. Compression therapy 12.15.3. Cryosurgery 12.15.4. Excision 12.15.5. Radiation therapy 12.15.6. Laser therapy 12.15.7. Interferon therapy 12.15.8. Intralesional corticosteroid injection 12.15.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid, and imiquimod) 12.16. ASEAN Keloid Treatment Market Forecast, By End User 12.16.1. Hospitals 12.16.2. Dermatology clinics 12.16.3. Ambulatory surgical centers 12.16.4. Others 12.17. ASEAN Keloid Treatment Market Forecast, By Treatment Type 12.17.1. Occlusive dressing 12.17.2. Compression therapy 12.17.3. Cryosurgery 12.17.4. Excision 12.17.5. Radiation therapy 12.17.6. Laser therapy 12.17.7. Interferon therapy 12.17.8. Intralesional corticosteroid injection 12.17.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid, and imiquimod) 12.18. Rest of Asia Pacific Keloid Treatment Market Forecast, By End User 12.18.1. Hospitals 12.18.2. Dermatology clinics 12.18.3. Ambulatory surgical centers 12.18.4. Others 12.19. Rest of Asia Pacific Keloid Treatment Market Forecast, By Treatment Type 12.19.1. Occlusive dressing 12.19.2. Compression therapy 12.19.3. Cryosurgery 12.19.4. Excision 12.19.5. Radiation therapy 12.19.6. Laser therapy 12.19.7. Interferon therapy 12.19.8. Intralesional corticosteroid injection 12.19.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 12.20. Asia Pacific Keloid Treatment Market Attractiveness Analysis 12.20.1. By End User 12.20.2. By Treatment Type 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Developments 13. Middle East & Africa Keloid Treatment Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Keloid Treatment Market Overview 13.3. Middle East & Africa Keloid Treatment Market Value Share Analysis, By End User 13.4. Middle East & Africa Keloid Treatment Market Forecast, By End User 13.4.1. Hospitals 13.4.2. Dermatology clinics 13.4.3. Ambulatory surgical centers 13.4.4. Others 13.5. Middle East & Africa Keloid Treatment Market Value Share Analysis, By Treatment Type 13.6. Middle East & Africa Keloid Treatment Market Forecast, By Treatment Type 13.6.1. Occlusive dressing 13.6.2. Compression therapy 13.6.3. Cryosurgery 13.6.4. Excision 13.6.5. Radiation therapy 13.6.6. Laser therapy 13.6.7. Interferon therapy 13.6.8. Intralesional corticosteroid injection 13.6.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 13.7. Middle East & Africa Keloid Treatment Market Value Share Analysis, by Country 13.8. Middle East & Africa Keloid Treatment Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Keloid Treatment Market Analysis, by Country 13.10. GCC Keloid Treatment Market Forecast, By End User 13.10.1. Hospitals 13.10.2. Dermatology clinics 13.10.3. Ambulatory surgical centers 13.10.4. Others 13.11. GCC Keloid Treatment Market Forecast, By Treatment Type 13.11.1. Occlusive dressing 13.11.2. Compression therapy 13.11.3. Cryosurgery 13.11.4. Excision 13.11.5. Radiation therapy 13.11.6. Laser therapy 13.11.7. Interferon therapy 13.11.8. Intralesional corticosteroid injection 13.11.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 13.12. South Africa Keloid Treatment Market Forecast, By End User 13.12.1. Hospitals 13.12.2. Dermatology clinics 13.12.3. Ambulatory surgical centers 13.12.4. Others 13.13. South Africa Keloid Treatment Market Forecast, By Treatment Type 13.13.1. Occlusive dressing 13.13.2. Compression therapy 13.13.3. Cryosurgery 13.13.4. Excision 13.13.5. Radiation therapy 13.13.6. Laser therapy 13.13.7. Interferon therapy 13.13.8. Intralesional corticosteroid injection 13.13.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 13.14. Rest of Middle East & Africa Keloid Treatment Market Forecast, By End User 13.14.1. Hospitals 13.14.2. Dermatology clinics 13.14.3. Ambulatory surgical centers 13.14.4. Others 13.15. Rest of Middle East & Africa Keloid Treatment Market Forecast, By Treatment Type 13.15.1. Occlusive dressing 13.15.2. Compression therapy 13.15.3. Cryosurgery 13.15.4. Excision 13.15.5. Radiation therapy 13.15.6. Laser therapy 13.15.7. Interferon therapy 13.15.8. Intralesional corticosteroid injection 13.15.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 13.16. Middle East & Africa Keloid Treatment Market Attractiveness Analysis 13.16.1. By End User 13.16.2. By Treatment Type 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Developments 14. South America Keloid Treatment Market Analysis 14.1. Key Findings 14.2. South America Keloid Treatment Market Overview 14.3. South America Keloid Treatment Market Value Share Analysis, By End User 14.4. South America Keloid Treatment Market Forecast, By End User 14.4.1. Hospitals 14.4.2. Dermatology clinics 14.4.3. Ambulatory surgical centers 14.4.4. Others 14.5. South America Keloid Treatment Market Value Share Analysis, By Treatment Type 14.6. South America Keloid Treatment Market Forecast, By Treatment Type 14.6.1. Occlusive dressing 14.6.2. Compression therapy 14.6.3. Cryosurgery 14.6.4. Excision 14.6.5. Radiation therapy 14.6.6. Laser therapy 14.6.7. Interferon therapy 14.6.8. Intralesional corticosteroid injection 14.6.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 14.7. South America Keloid Treatment Market Value Share Analysis, by Country 14.8. South America Keloid Treatment Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Keloid Treatment Market Analysis, by Country 14.10. Brazil Keloid Treatment Market Forecast, By End User 14.10.1. Hospitals 14.10.2. Dermatology clinics 14.10.3. Ambulatory surgical centers 14.10.4. Others 14.11. Brazil Keloid Treatment Market Forecast, By Treatment Type 14.11.1. Occlusive dressing 14.11.2. Compression therapy 14.11.3. Cryosurgery 14.11.4. Excision 14.11.5. Radiation therapy 14.11.6. Laser therapy 14.11.7. Interferon therapy 14.11.8. Intralesional corticosteroid injection 14.11.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid, and imiquimod) 14.12. Mexico Keloid Treatment Market Forecast, By End User 14.12.1. Hospitals 14.12.2. Dermatology clinics 14.12.3. Ambulatory surgical centers 14.12.4. Others 14.13. Mexico Keloid Treatment Market Forecast, By Treatment Type 14.13.1. Occlusive dressing 14.13.2. Compression therapy 14.13.3. Cryosurgery 14.13.4. Excision 14.13.5. Radiation therapy 14.13.6. Laser therapy 14.13.7. Interferon therapy 14.13.8. Intralesional corticosteroid injection 14.13.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid, and imiquimod) 14.14. Rest of South America Keloid Treatment Market Forecast, By End User 14.14.1. Hospitals 14.14.2. Dermatology clinics 14.14.3. Ambulatory surgical centers 14.14.4. Others 14.15. Rest of South America Keloid Treatment Market Forecast, By Treatment Type 14.15.1. Occlusive dressing 14.15.2. Compression therapy 14.15.3. Cryosurgery 14.15.4. Excision 14.15.5. Radiation therapy 14.15.6. Laser therapy 14.15.7. Interferon therapy 14.15.8. Intralesional corticosteroid injection 14.15.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod) 14.16. South America Keloid Treatment Market Attractiveness Analysis 14.16.1. By End User 14.16.2. By Treatment Type 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Vehicles, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Vehicles 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Revitol Corporation Inc. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Xstrahl Medical 15.3.3. GlaxoSmithKline plc. 15.3.4. Bristol-Myers Squibb Company 15.3.5. Sensus Healthcare, Inc 15.3.6. Novartis AG, Renovo Group plc. 15.3.7. Bausch Health 15.3.8. Scarless Laboratories Inc. 15.3.9. Galena Biopharma, Inc. 15.3.10. RXi Pharmaceuticals, Inc. 15.3.11. Avita Medical 15.3.12. Perrigo Company 15.3.13. Soliton, Inc 16. Primary Key Insights

About This Report

Report ID65786
Category Healthcare
Published DateJuly 2020
No of Pages193
Contact Us